Department of Medicine, Faculty of Medicine, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah, Saudi Arabia.
Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Ren Fail. 2023 Dec;45(1):2224456. doi: 10.1080/0886022X.2023.2224456.
Patients with chronic kidney disease, especially those undergoing hemodialysis (HD), have a higher risk of fragility fractures. However, the magnitude of the problem and risk factors associated with fracture incidence have not been well studied in the Kingdom of Saudi Arabia.
This multicenter retrospective study involved HD centers in Jeddah from 2015 to 2021. This study included all adult HD patients. Patient demographics, medication usage, and clinical and biochemical parameters were collected from the registry records.
The study included 328 patients on HD, with a mean age of 53 years. The median duration of HD was 47 months. Osteoporosis was found in 9% of the patients, and 8% had a previous parathyroidectomy. Over the observation period, fractures occurred in 32 patients, with an incidence rate of 20 case/1000 end stage kidney disease patients-year. Patients with fractures had a higher rate of osteoporosis, underwent more parathyroidectomy, had longer HD vintage, and higher bone-specific alkaline phosphatase (BSAP) levels. BSAP was the most significant predictor of fracture incidence in the regression analysis. Using a BSAP cutoff value of 96.6 µg/L, the sensitivity and specificity to predict fractures were 81.8% and 49%, respectively.
The main risk factors for incident fractures were osteoporosis, previous parathyroidectomy, longer HD vintage, and higher BSAP level. A higher BSAP score was the most significant predictor of incident fractures. This may highlight the importance of monitoring bone turnover markers and the negative impact of high bone turnover on patient health.
慢性肾脏病患者,尤其是接受血液透析(HD)治疗的患者,脆性骨折风险较高。然而,沙特阿拉伯王国尚未对该问题的严重程度及其与骨折发生率相关的风险因素进行充分研究。
本多中心回顾性研究纳入了 2015 年至 2021 年期间吉达的 HD 中心的患者。该研究纳入了所有成年 HD 患者。从登记记录中收集了患者的人口统计学、药物使用情况以及临床和生化参数。
该研究纳入了 328 名接受 HD 治疗的患者,平均年龄为 53 岁。HD 的中位时间为 47 个月。9%的患者存在骨质疏松症,8%的患者曾接受甲状旁腺切除术。在观察期间,32 名患者发生骨折,发病率为 20 例/1000 例终末期肾病患者年。骨折患者的骨质疏松症发生率更高,接受甲状旁腺切除术的次数更多,HD 治疗时间更长,且骨特异性碱性磷酸酶(BSAP)水平更高。BSAP 是回归分析中骨折发生率的最显著预测因子。使用 BSAP 截断值 96.6 µg/L,预测骨折的灵敏度和特异性分别为 81.8%和 49%。
骨折的主要危险因素是骨质疏松症、甲状旁腺切除术、HD 治疗时间更长和 BSAP 水平更高。较高的 BSAP 评分是骨折发生的最显著预测因子。这可能突出了监测骨转换标志物的重要性以及高骨转换对患者健康的负面影响。